Eva Resel
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Δ9 -Tetrahydrocannabinol promotes functional remyelination in the mouse brain.
Journal: British journal of pharmacology
Published: April 22, 2021
Cannabinoid-induced motor dysfunction via autophagy inhibition.
Journal: Autophagy
Published: September 28, 2020
Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons.
Journal: Neuropharmacology
Published: February 04, 2019
Glucose metabolism links astroglial mitochondria to cannabinoid effects.
Journal: Nature
Published: March 09, 2018
Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: July 04, 2017
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 04, 2016
Sustained Gq-Protein Signaling Disrupts Striatal Circuits via JNK.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: April 08, 2016
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.
Journal: Journal of neurology
Published: February 22, 2016
The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway.
Journal: Cell death and differentiation
Published: July 15, 2014
A restricted population of CB1 cannabinoid receptors with neuroprotective activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 21, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026